Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 377 | 1,094 | 52 | 0 | 0 |
| Gross Profit | 377 | 1,094 | 52 | N/A | N/A |
| Operating Expenses | 5,772 | 5,825 | 6,023 | 4,611 | 3,437 |
| Operating Income | -5,395 | -4,731 | -5,971 | -4,611 | -3,437 |
| Other Income | 270 | 212 | 150 | 64 | 36 |
| Pre-tax Income | -5,125 | -4,519 | -5,821 | -4,547 | -3,401 |
| Net Income Continuous | -5,125 | -4,519 | -5,821 | -4,547 | -3,401 |
| Net Income | $-5,125 | $-4,519 | $-5,821 | $-4,547 | $-3,401 |
| EPS Basic Total Ops | -293.91 | -251.92 | 839.75 | -1,245.63 | -15,507.35 |
| EPS Basic Continuous Ops | -293.91 | -256.51 | -1,023.10 | -822.66 | -615.46 |
| EPS Diluted Total Ops | -293.91 | -251.92 | -363.89 | -811.76 | -15,507.35 |
| EPS Diluted Continuous Ops | -290.92 | -256.51 | -362.80 | -1,146.20 | -615.46 |
| EBITDA(a) | $-5,598 | $-4,964 | $-5,936 | $-4,518 | $-3,348 |